Nxi Therapeutics Ag
NXI therapeutics focuses on the research and development of a new generation of selective immunosuppressive drugs for autoimmune diseases and transplantations - with objectives of high efficacy, good safety without adverse effects as seen with conventional immunosuppressants.
7-day free trial · no credit card
Verified contacts
4
available on Kipplo
LinkedIn employees
5
1 to 10 range
Open roles
—
no listings
Distinct roles
3
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 4 verified contacts at Nxi Therapeutics Ag
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
4 contacts with verified email or phone · masked until revealed.
- RJ
Rajesh Jayachandran
Chief Scientific Officer, Co-founder · Science
EmailPhone - RE
Reto Erni
Projektmanager Medicinal Chemistry · Other
EmailPhone
Showing 2 of 4 verified contacts
Top roles at Nxi Therapeutics Ag
3 distinct titles indexed · top 3 shown.
- 1chief scientific officer, co-founder
- 1digital specialist
- 1projektmanager medicinal chemistry
Sign up to unlock all 4 contacts at Nxi Therapeutics Ag
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 4 verified contacts at Nxi Therapeutics Ag
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.